DexCom Inc. Stock Underperforms Monday When Compared To Competitors

Citigroup Inc

Change company Symbol lookup

Select an option...

C Citigroup Inc

DG Dollar General Corp

DHI D R Horton Inc

CNP CenterPoint Energy Inc

BLUA Blueriver Acquisition Corp

GMER Good Gaming Inc

BICX BioCorRx Inc

VEII Value Exchange International Inc

NROM Noble Roman's Inc

FVTI Fortune Valley Treasures Inc

Financials : Banks | Large Cap Value

Company profile

Citigroup Inc. is a diversified financial service holding company. The Company provides a range of financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, trade and securities services and wealth management. It operates through two segments: Institutional Clients Group (ICG) and Global Consumer Banking (GCB). ICG segment consists of banking and markets and securities services and provides corporate, institutional, public sector and high-net-worth clients with a range of banking and financial products and services. GCB segment includes a global, full-service consumer franchise delivering an array of banking, credit card, lending and investment services through a network of local branches, offices and electronic delivery systems. It consists of three GCB units, which include North America, Latin America and Asia, including consumer banking activities in certain Europe, the Middle East and Africa (EMEA) countries.

DexCom Inc. Stock Underperforms Monday When Compared To Competitors

4:51 pm ET January 10, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of DexCom Inc. (DXCM) slipped 1.94% to $462.34 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.14% to 4,670.29 and Dow Jones Industrial Average falling 0.45% to 36,068.87. This was the stock's seventh consecutive day of losses. DexCom Inc. closed $197.11 below its 52-week high ($659.45), which the company reached on November 18th.

The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) fell 0.49% to $173.09, Abbott Laboratories (ABT) fell 0.22% to $135.26, and Medtronic PLC (MDT) rose 0.44% to $105.62. Trading volume (1.4 M) eclipsed its 50-day average volume of 758,899.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 10, 2022.

-MarketWatch Automation

(END) Dow Jones Newswires

January 10, 2022 16:51 ET (21:51 GMT)